10 results
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
commonly used diabetic ... drugs. ... #pharmacology #dm2 ... #overview #management ... #comparison
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
anti-coagulation drugs ... anticoagulation #pharmacology ... medications #doac #comparison ... #table #management ... #drugs
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... Benefits of these drugs ... #Pharmacology # ... Medications #DM2 ... #Diabetes #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
thing about this drug ... This drug class ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Protease Inhibitors 

Protease Inhibitors are a class of commonly used antiretroviral medications for management of HIV.
Protease Inhibitors ... medications for management ... Here's a broad overview ... there are a ton of drug ... #HIV #Pharmacology
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
immune deficiency, Drugs ... Etoposide/VP16 (100 mg/m2 ... of emergency, ICU ... Anti-IFN-y and JAK inhibitors ... Lymphohistiocytosis #diagnosis #management
GLP-1 Medications: Ozempic vs. Trulicib (semaglutide vs. dulaglutide) 

From my experience, Ozempic and Trulicity are the
Hopefully this overview ... only for type 2 diabetes ... consider these drugs ... #dulaglutide #Pharmacology ... #Diabetes #Comparison
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... necrosis factor-α inhibitors ... • Injection drug ... kidney disease • DM ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... necrosis factor-α inhibitors ... • Injection drug ... kidney disease • DM ... TB #Diagnosis #Management
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
Overview of antifungal ... tolerable • High MIC ... • Therapeutic drug ... #valleyfever #management ... #table #pharmacology